Philip Kuehl
Phil is head of science and technology at Aptar Pharma. He is an experienced drug development expert with over 20 years of experience in development of respiratory, intranasal, gene therapy, infectious disease and other drug programs. Expert in the area of pulmonary dose within non-clinical and clinical drug delivery systems. Extensive experience in the development and design of drug development programs to assess pharmacology, pharmacokinetics and toxicology throughout all stages of drug development. Record of publication in refereed journals and invited speaker at international scientific conferences. Current member of ISAM board, editorial board for JAMPDD, AAPS PharmSciTech and Frontiers in Drug Delivery Respiratory Drug Delivery and Research Associate Professor at the University of New Mexico College of Pharmacy.